Track Bio-Techne Corporation — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Bio-Techne Corporation TECH · Stock Open Bio-Techne Corporation in new tab

72.80 USD
P/E
62.74
EPS
1.16
Yield
0.44%
Safety Score
92
P/B
5.28
ROE
8.33
Beta
1.28
Target Price
70.50 USD
Bio-Techne Corporation logo

Bio-Techne Corporation

🧾 Earnings Recap – Q3 2026

Bio-Techne’s shares fell 10.2% following the quarter, as investor disappointment centered on continued organic revenue deceleration driven by emerging biotech weakness and cautious near-term outlook despite some pockets of growth and margin improvement.

  • Organic revenue declined 2% for the quarter, weighed down by high single-digit declines in emerging biotech spending.
  • Large pharma segment sustained low double-digit growth for its sixth consecutive quarter, while U.S. academia returned to low single-digit growth.
  • Adjusted operating margin improved sequentially by 310 basis points to 34.2%, reflecting disciplined cost management.
  • Order timing from two fast track cell therapy customers and a large OEM supply order created a 400 basis point headwind.
  • China market continued positive organic growth for the fourth quarter in a row, driven by demand in biopharma and CRO sectors.
📅
Loading chart...
Key Metrics
Earnings dateFeb. 2, 2027
P/E62.74
EPS1.16
Book Value13.79
Price to Book5.28
Debt/Equity13.19
% Insiders0.399%
Growth
Revenue Growth0.05%
Earnings Growth-0.25%
Estimates
Forward P/E31.49
Forward EPS2.31
Target Mean Price70.50
Dividend
Dividend Yield0.44%
Annual dividends0.32 USD
Ex-Div. DateNov. 13, 2026
Payout27.45%
5y avg Yield0.41%

DCF valuation

Model fair value for Bio-Techne Corporation (TECH)
Result
Sign in to run the valuation for TECH.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
10 analysts · consensus Hold · mean target 70.50 USD (low 50.00, high 73.00) · as of 9 Nov 2026
Low 50.00
Mean 70.50
High 73.00
Price 72.80
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Bio-Techne Corporation Logo Bio-Techne Corporation Analysis (TECH)

United States Health Care Official Website Stock

Is Bio-Techne Corporation a good investment? Bio-Techne Corporation (TECH) is currently trading at 72.80 USD. Market analysts have a consensus price target of 70.50 USD. This suggests the asset is currently trading above analyst expectations.

In terms of valuation, the stock trades at a P/E ratio of 62.74. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Bio-Techne Corporation is expected to release its next earnings report on Feb. 2, 2027. The market consensus estimate for Forward EPS is 2.31.

For income investors, Bio-Techne Corporation pays a dividend yield of 0.44%. With a payout ratio of 27%, the dividend appears sustainable.

Investor FAQ

Does Bio-Techne Corporation pay a dividend?

Yes, it pays an annual dividend of 0.32 USD (0.44% yield).

What asset class is Bio-Techne Corporation?

Bio-Techne Corporation is classified as a Stock. You can compare it against 4 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Feb. 2, 2027. The company currently has a trailing EPS of 1.16.

Company Profile

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. It operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. Its Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.

Exchange Ticker
TE1.SG
FRA (Germany) TE1.F
SAO (Brazil) T1CH34.SA
NMS (United States) TECH
Trades
Dividend Yield
0.44%
5y avg 0.41%
Annual Dividends
0.32USD
Next Ex. Div Date
Nov. 13, 2026
Payout Ratio
27.45%
Dividend History paid per year (USD)
Historical Dividends
Year Total Dividends
▸2027
0.24 USD
Aug. 31, 2027 (estimated) 0.0800
May 27, 2027 (estimated) 0.0800
Feb. 26, 2027 (estimated) 0.0800
▸2026
0.32 USD
Nov. 23, 2026 0.0800
Aug. 28, 2026 0.0800
May 29, 2026 0.0800
Feb. 27, 2026 0.0800
▸2025
0.32 USD
Nov. 28, 2025 0.0800
Aug. 29, 2025 0.0800
May 30, 2025 0.0800
Feb. 28, 2025 0.0800
▸2024
0.32 USD
Nov. 22, 2024 0.0800
Aug. 30, 2024 0.0800
May 24, 2024 0.0800
Feb. 26, 2024 0.0800
▸2023
0.32 USD
Nov. 24, 2023 0.0800
Sept. 1, 2023 0.0800
May 26, 2023 0.0800
Feb. 27, 2023 0.0800
▸2022
1.60 USD
Nov. 28, 2022 0.3200
Nov. 28, 2022 0.0800
Aug. 29, 2022 0.3200
Aug. 29, 2022 0.0800
May 27, 2022 0.3200
May 27, 2022 0.0800
Feb. 25, 2022 0.3200
Feb. 25, 2022 0.0800
▸2021
1.60 USD
Nov. 26, 2021 0.3200
Nov. 26, 2021 0.0800
Aug. 27, 2021 0.3200
Aug. 27, 2021 0.0800
May 28, 2021 0.3200
May 28, 2021 0.0800
Feb. 26, 2021 0.3200
Feb. 26, 2021 0.0800
▸2020
1.60 USD
Nov. 27, 2020 0.3200
Nov. 27, 2020 0.0800
Aug. 28, 2020 0.3200
Aug. 28, 2020 0.0800
May 22, 2020 0.3200
May 22, 2020 0.0800
Feb. 28, 2020 0.3200
Feb. 28, 2020 0.0800
▸2019
1.60 USD
Nov. 22, 2019 0.3200
Nov. 22, 2019 0.0800
Aug. 30, 2019 0.3200
Aug. 30, 2019 0.0800
May 24, 2019 0.3200
May 24, 2019 0.0800
March 1, 2019 0.3200
March 1, 2019 0.0800
▸2018
1.60 USD
Nov. 23, 2018 0.3200
Nov. 23, 2018 0.0800
Aug. 31, 2018 0.3200
Aug. 31, 2018 0.0800
May 25, 2018 0.3200
May 25, 2018 0.0800
March 2, 2018 0.3200
March 2, 2018 0.0800
▸2017
1.60 USD
Nov. 24, 2017 0.3200
Nov. 24, 2017 0.0800
Sept. 1, 2017 0.3200
Sept. 1, 2017 0.0800
June 2, 2017 0.3200
June 2, 2017 0.0800
March 3, 2017 0.3200
March 3, 2017 0.0800
▸2016
1.60 USD
Nov. 28, 2016 0.3200
Nov. 28, 2016 0.0800
Sept. 12, 2016 0.3200
Sept. 12, 2016 0.0800
May 27, 2016 0.3200
May 27, 2016 0.0800
Feb. 26, 2016 0.3200
Feb. 26, 2016 0.0800
▸2015
1.60 USD
Nov. 27, 2015 0.3200
Nov. 27, 2015 0.0800
Aug. 28, 2015 0.3200
Aug. 28, 2015 0.0800
May 29, 2015 0.3200
May 29, 2015 0.0800
Feb. 27, 2015 0.3200
Feb. 27, 2015 0.0800
▸2014
1.56 USD
Nov. 24, 2014 0.3200
Nov. 24, 2014 0.0800
Aug. 29, 2014 0.3100
Aug. 29, 2014 0.0775
May 23, 2014 0.3100
May 23, 2014 0.0775
Feb. 28, 2014 0.3100
Feb. 28, 2014 0.0775
▸2013
1.51 USD
Nov. 25, 2013 0.3100
Nov. 25, 2013 0.0775
Aug. 30, 2013 0.3000
Aug. 30, 2013 0.0750
May 24, 2013 0.3000
May 24, 2013 0.0750
March 1, 2013 0.3000
March 1, 2013 0.0750
▸2012
1.43 USD
Nov. 19, 2012 0.3000
Nov. 19, 2012 0.0750
Aug. 24, 2012 0.2800
Aug. 24, 2012 0.0700
May 25, 2012 0.2800
May 25, 2012 0.0700
Feb. 24, 2012 0.2800
Feb. 24, 2012 0.0700
▸2011
1.36 USD
Nov. 21, 2011 0.2800
Nov. 21, 2011 0.0700
Aug. 26, 2011 0.2700
Aug. 26, 2011 0.0675
May 27, 2011 0.2700
May 27, 2011 0.0675
Feb. 28, 2011 0.2700
Feb. 28, 2011 0.0675
▸2010
1.31 USD
Nov. 22, 2010 0.2700
Nov. 22, 2010 0.0675
Aug. 31, 2010 0.2600
Aug. 31, 2010 0.0650
May 28, 2010 0.2600
May 28, 2010 0.0650
Feb. 26, 2010 0.2600
Feb. 26, 2010 0.0650
▸2009
1.26 USD
Nov. 23, 2009 0.2600
Nov. 23, 2009 0.0650
Aug. 31, 2009 0.2500
Aug. 31, 2009 0.0625
May 22, 2009 0.2500
May 22, 2009 0.0625
Feb. 27, 2009 0.2500
Feb. 27, 2009 0.0625
▸2008
0.31 USD
Nov. 17, 2008 0.2500
Nov. 17, 2008 0.0625
Upcoming Dividends
Name Payment Date Status Amount
Bio-Techne Corporation Nov 23, 2026 Upcoming 0.08 USD
Bio-Techne Corporation Aug 28, 2026 0.08 USD
Bio-Techne Corporation May 29, 2026 0.08 USD
Bio-Techne Corporation Feb 27, 2026 0.08 USD
Bio-Techne Corporation Nov 28, 2025 0.08 USD
Stock Splits
Split Date Split Ratio to 1
Nov. 18, 1997 2:1
Dec. 4, 2000 2:1
Nov. 30, 2022 4:1
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion